Price
CHART BY
Frequently asked questions
What is Upexi's market capitalization?
The market capitalization of Upexi is $97.70M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Upexi?
Upexi's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$4.168. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Upexi's stock?
Currently, 1 analysts cover Upexi's stock, with a consensus target price of $2.00. Analyst ratings provide insights into the stock's expected performance.
What is Upexi's revenue over the trailing twelve months?
Over the trailing twelve months, Upexi reported a revenue of $25.00M.
What is the EBITDA for Upexi?
Upexi's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$31.45M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Upexi?
Upexi has a free cash flow of -$28.63M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Upexi have, and what sector and industry does it belong to?
Upexi employs approximately 10 people. It operates in the Financials sector, specifically within the Other Pharmaceuticals industry.
What is the free float of Upexi's shares?
The free float of Upexi is 61.37M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $97.70M
- EPS (TTM)
- -$4.168
- Free Float
- 61.37M
- Revenue (TTM)
- $25.00M
- EBITDA (TTM)
- -$31.45M
- Free Cashflow (TTM)
- -$28.63M
Pricing
- 1D span
- $1.205$1.286
- 52W span
- $0.54$7.75
Analyst Ratings
The price target is $2.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.
- Employees
- 10
- Industries
- Other Pharmaceuticals
- Sector
- Financials
Identifier
- Primary Ticker
- UPXI
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet